Formulary Policy For Biosimilars In Part D Clarified In CMS Guidance
This article was originally published in The Pink Sheet Daily
Executive Summary
Guidance for Medicare Part D released March 30 addresses formulary review policies, cost-sharing rules and coverage-gap discounts, while a Part B guidance addresses coding and payment formulas.